Catch pre-market movers with AI signals.
IGMS(Quitar la ciudad)
IGM Biosciences (IGMS) Stock Statistics, Valuation & Financial Metrics
Total Valuation
IGM Biosciences market cap is -- and enterprise value is --.
Share Statistics
IGM Biosciences has 60.29M shares outstanding, with a free float of 17.64M.
Valuation Ratios
IGM Biosciences's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
IGM Biosciences debt-to-equity ratio is -- and debt-to-assets ratio is 0.06.
Liquidity
IGM Biosciences's current ratio is 17.66, quick ratio is 17.66, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
IGM Biosciences's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
IGM Biosciences gross margin is 100.00%, operating margin is -42.66%, and net margin is -36.80%.
Cost Structure
IGM Biosciences spends 71.20% of revenue on R&D and 34.37% on SG&A.
Operating Efficiency
IGM Biosciences's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
IGM Biosciences's revenue is 145.05M, gross profit is 145.05M, net income is --, and EBITDA is --.
Balance Sheet
IGM Biosciences's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
IGM Biosciences's operating cash flow is -156.51M, free cash flow is -158.70M, and CapEx is -2.19M.
Dividends & Yields
IGM Biosciences dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
IGM Biosciences's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage biotech company focused on creating and developing IgM antibodies
Per Share Metrics
IGM Biosciences's EPS is --, book value per share is --, and free cash flow per share is --.
